Evoke Pharma - 11 Year Stock Price History | EVOK

Historical daily share price chart and data for Evoke Pharma since 2013 adjusted for splits and dividends. The latest closing stock price for Evoke Pharma as of April 18, 2024 is 0.48.
  • The all-time high Evoke Pharma stock closing price was 167.88 on October 04, 2013.
  • The Evoke Pharma 52-week high stock price is 2.40, which is 400% above the current share price.
  • The Evoke Pharma 52-week low stock price is 0.42, which is 12.5% below the current share price.
  • The average Evoke Pharma stock price for the last 52 weeks is 1.21.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Evoke Pharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 0.6786 1.0300 1.0700 0.4700 0.4788 -54.41%
2023 1.9167 2.7001 5.7500 0.9624 1.0503 -60.81%
2022 3.7825 7.1088 10.3200 1.4373 2.6800 -59.39%
2021 19.0622 32.4000 52.9200 6.6000 6.6000 -78.68%
2020 34.0040 19.2000 68.4000 9.8388 30.9600 59.26%
2019 15.4076 30.6000 38.4000 6.3624 19.4400 -34.68%
2018 30.7099 28.2000 39.9600 22.8000 29.7600 9.73%
2017 33.1877 24.8400 46.5600 24.8400 27.1200 11.88%
2016 42.0255 39.1200 130.6800 17.2800 24.2400 -38.79%
2015 59.9733 72.4800 94.2000 30.7200 39.6000 -44.07%
2014 90.5944 92.5200 142.3200 56.6400 70.8000 -20.81%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.005B $0.005B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.776B 5.34
Dr Reddy's Laboratories (RDY) India $11.900B 18.82
Aspen Pharmacare (APNHY) South Africa $5.172B 0.00
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Bausch Health Cos (BHC) Canada $3.164B 2.47
Amphastar Pharmaceuticals (AMPH) United States $1.957B 13.40
Supernus Pharmaceuticals (SUPN) United States $1.587B 0.00
Taysha Gene Therapies (TSHA) United States $0.458B 0.00
Generation Bio (GBIO) United States $0.198B 0.00
Assembly Biosciences (ASMB) United States $0.071B 0.00
Personalis (PSNL) United States $0.061B 0.00
Acasti Pharma (ACST) Canada $0.030B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Teligent (TLGT) United States $0.000B 0.00